Product Details
Rapid Test Kit SARS-CoV-2 Antigen & Influenza A/B rapid Test Kit
High Accuracy Rapid Test Kit
Intended Use
- Immunochromatography assay
- Intended for the qualitative detection and differenttiation of
nucleocapsid protein antigens from SARS-CoV-2 influenza type A and
influenza type B in the same time.
- Nasal/nasopharyngeal (NS/NP) swab, oropharyngeal (OP) swab and
saliva specimens from patients with signs and symptoms of
respiratory viral infection.
- The test result should be conjunction with clinical presentation
and results of other laboratory tests to diagnostic.
- Results from this test kit should not be used as the sole basis for
diagnosis.
Specification
Item | Antigen test strip performance against PCR | Influenza A test strip performance against PCR | Influenza B test strip performance against PCR |
Sensitivity | 98.03% | 93.30% | 97.00% |
Specificity | 100.00% | 91.00% | 96.40% |
Main Components
- Test cassettes
- Sample extraction
- Sample tubes
- Swabs
- Instruction Manual
Feature
- CE Marked
- Nasal swab sample
- 3 items in one cassette
- Result in 15 minutes
Use Step
- Take out the test cassette from the sealed pouch, place it on a
clean and level surface with the sample port well up.
Apply 2 full drops of the treated sample (60μl-70μl) vertically
into each of the two sample wells of the test cassette.
Observe the test results immediately within 15~20 minutes, the
result is invalid over 20 minutes.
Interpretation Of Result
POSITIVE: The presence of T (T on nCoV /A or B on Flu) and C lines within
the reaction window indicate a positive result on SARS-CoV-2 or Flu
A and/or B infection or co-infection.
NEGATIVE: One colored line appears in the control region(C). No apparent
colored line appears in the test region (T on nCoV /A or B on Flu).
The negative result does not indicate the absence of analytes in
the sample, it only indicates the level of tested analytes in the
sample is less than the minimum detection limit
INVALID: No colored lines appear, or control line fails to appear,
indicating that the operator error or reagent failure. Verify the
test procedure and repeat the test with a new testing device.
Advantage
- High Accuracy, Specificity and Sensitivity
- Detection of mutation
- Safety and Reliabkle
- Simple Operation without Extra Instrument
- Results in 15 minutes and easy to read
Company Profile
Labnovation Technologies, Inc. is an original manufacturer
established in Shenzhen, China since 2001. We are dedicated in
developing and manufacturing IVD instruments and reagents including
HbA1c analyzer and reagents, rapid test reader & reagents,
hematology reagents, clinical chemistry reagents, electrolyte
reagents, wash solution and urine test reagents.
Labnovation products are developed in house, tested extensively in
clinics and passed strict quality controls. All of our products are
CE marked and approved by SFDA. In the past 15 years, our products
have been exported to 110 different countries and used in 8000
hospitals worldwide. We provide both ready-to-use final products
and bulk OEM reagents, including ready-to-use reagents,
concentrated, and powder.
With an investment of 10% of our annual sales into R&D, we
release new products every years. We win more and more domestic and international cooperation by
company reputation and products quality while we actively take part
in fairs like MEDICA,AACC, ARBA HEALTH and so on through which we
are well-known by the companies in this field.